UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 895

Sortiert nach

Nearly 100% Internal Quantum Efficiency in Undoped Electroluminescent Devices Employing Pure Organic Emitters

Advanced materials (Weinheim), 2015-03, Vol.27 (12), p.2096-2100

2015

Link zum Volltext

Verfügbarkeit prüfen

Sex differences in immune responses

Science (American Association for the Advancement of Science), 2021-01, Vol.371 (6527), p.347-348

2021

Link zum Volltext

Verfügbarkeit prüfen

Fibrosis, Vascular Activation, and Immune Abnormalities Resembling Systemic Sclerosis in Bleomycin‐Treated Fli‐1–Haploinsufficient Mice

Arthritis & rheumatology (Hoboken, N.J.), 2015-02, Vol.67 (2), p.517-526

2015

Link zum Volltext

Verfügbarkeit prüfen

Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease

Journal of dermatology, 2019-11, Vol.46 (11), p.1006-1013

2019

Link zum Volltext

Verfügbarkeit prüfen

Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma

The Journal of experimental medicine, 2017-04, Vol.214 (4), p.1129-1151

2017

Link zum Volltext

Verfügbarkeit prüfen

Donor-acceptor-structured 1,4-diazatriphenylene derivatives exhibiting thermally activated delayed fluorescence: design and synthesis, photophysical properties and OLED characteristics

Science and technology of advanced materials, 2014-06, Vol.15 (3), p.034202-10

2014

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis

Nature communications, 2014-12, Vol.5 (1), p.5797-5797, Article 5797

2014

Link zum Volltext

Verfügbarkeit prüfen

Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma‐like Vasculopathy in KLF5+/−;Fli‐1+/− Mice

Arthritis & rheumatology (Hoboken, N.J.), 2020-12, Vol.72 (12), p.2136-2146

2020

Link zum Volltext

Verfügbarkeit prüfen

Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis

Proceedings of the National Academy of Sciences - PNAS, 2015-12, Vol.112 (49), p.15136-15141

2015

Link zum Volltext

Verfügbarkeit prüfen

CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis

Experimental dermatology, 2018-09, Vol.27 (9), p.1030-1037

2018

Link zum Volltext

Verfügbarkeit prüfen

Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis

Journal of investigative dermatology, 2017-03, Vol.137 (3), p.631-640

2017

Link zum Volltext

Verfügbarkeit prüfen

Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency

Journal of investigative dermatology, 2017-09, Vol.137 (9), p.1850-1859

2017

Link zum Volltext

Verfügbarkeit prüfen

Amelioration of Tissue Fibrosis by Toll‐like Receptor 4 Knockout in Murine Models of Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2015-01, Vol.67 (1), p.254-265

2015

Link zum Volltext

Verfügbarkeit prüfen

Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis

Rheumatology (Oxford, England), 2020-08, Vol.59 (8), p.2005-2015

2020

Link zum Volltext

Verfügbarkeit prüfen

Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis

Journal of rheumatology, 2017-08, Vol.44 (8), p.1198

2017

Link zum Volltext

Verfügbarkeit prüfen

Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study

Journal of dermatology, 2018-12, Vol.45 (12), p.1425-1433

2018

Link zum Volltext

Verfügbarkeit prüfen

Challenges in interpreting cytokine data in COVID-19 affect patient care and management

PLoS biology, 2021-08, Vol.19 (8), p.e3001373-e3001373

2021

Link zum Volltext

Verfügbarkeit prüfen

Endothelin Receptor Blockade Ameliorates Vascular Fragility in Endothelial Cell–Specific Fli‐1–Knockout Mice by Increasing Fli‐1 DNA Binding Ability

Arthritis & rheumatology (Hoboken, N.J.), 2015-05, Vol.67 (5), p.1335-1344

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre‐enfortumab vedotin era

International journal of urology, 2022-07, Vol.29 (7), p.647-655

2022

Link zum Volltext

Verfügbarkeit prüfen

Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells

Arthritis research & therapy, 2018-02, Vol.20 (1), p.23-23, Article 23

2018

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis

Rheumatology (Oxford, England), 2015-07, Vol.54 (7), p.1308-1316

2015

Link zum Volltext

Verfügbarkeit prüfen

Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells

Journal of investigative dermatology, 2016-02, Vol.136 (2), p.387-398

2016

Link zum Volltext

Verfügbarkeit prüfen

A Three-Level GaN Driver for High False Turn-ON Tolerance with Minimal Reverse Conduction Loss

IEEE open journal of power electronics, 2023-01, Vol.4, p.1-10

2023

Link zum Volltext

Verfügbarkeit prüfen

Progranulin Overproduction Due to Fli‐1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2015-12, Vol.67 (12), p.3245-3255

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 895

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(659)
Mit Volltextzugriff
(806)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(488)
Life Sciences & Biomedicine
(338)
Humans
(242)
Female
(154)
Male
(153)
Middle Aged
(122)
Aged
(94)
Technology
(89)
Physical Sciences
(88)
Animals
(70)
Adult
(65)
Systemic Sclerosis
(54)
Engineering
(53)
Surgery
(50)
Medicine
(49)
Dermatology
(45)
Engineering, Electrical & Electronic
(44)
Medicine & Public Health
(44)
Mice
(42)
Optics
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Dermatology
(24)
The Journal Of Dermatology
(22)
鉄と鋼
(18)
Modern Rheumatology
(13)
Internal Medicine
(12)
Tetsu To Hagane
(12)
Nihon Kikai Gakkai Rombunshuu. B Hen
(11)
Gan To Kagaku Ryoho
(10)
Journal Of Clinical Oncology
(10)
Journal Of Lightwave Technology
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Nearly 100% Internal Quantum Efficiency in Undoped Electroluminescent Devices Employing Pure Organic Emitters

Sex differences in immune responses

Fibrosis, Vascular Activation, and Immune Abnormalities Resembling Systemic Sclerosis in Bleomycin‐Treated Fli‐1–Haploinsufficient Mice

Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease

Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma

Donor-acceptor-structured 1,4-diazatriphenylene derivatives exhibiting thermally activated delayed fluorescence: design and synthesis, photophysical properties and OLED characteristics

Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis

Impaired Insulin Signaling in Endothelial Cells Reduces Insulin-Induced Glucose Uptake by Skeletal Muscle

Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma‐like Vasculopathy in KLF5+/−;Fli‐1+/− Mice

Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis

CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis

Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis

Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency

Amelioration of Tissue Fibrosis by Toll‐like Receptor 4 Knockout in Murine Models of Systemic Sclerosis

Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis

Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis

Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study

Challenges in interpreting cytokine data in COVID-19 affect patient care and management

Endothelin Receptor Blockade Ameliorates Vascular Fragility in Endothelial Cell–Specific Fli‐1–Knockout Mice by Increasing Fli‐1 DNA Binding Ability

Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre‐enfortumab vedotin era

Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells

Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis

Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells

A Three-Level GaN Driver for High False Turn-ON Tolerance with Minimal Reverse Conduction Loss

Progranulin Overproduction Due to Fli‐1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis

Aktive Filter

Suchergebnisse filtern